More than 80% of tumors originate in epithelial cells, the most common type of cells in the human body. They are found in a wide array of organs, forming the linings and surfaces......
AFCR April 2018 China Brain Cancer Round Table
(clockwise) AFCR Founder and CEO Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin Bringing International Partners Together In recent months, the Asian Fund for Cancer Research (AFCR) has established relationships with two fellow Pacific Rim institutions: the China Pharmaceutical Innovation and Research Development…...
AFCR-Supported Scientist Discovers Critical Molecular Interaction, Opens New Avenue for Cancer Drug Development
(Hong Kong, April 13, 2015) Prof. Mingjie Zhang of Hong Kong University of Science and Technology, a scientist supported by the Asian Fund for Cancer Research (AFCR), recently discovered a critical molecular interaction governing epithelial cell polarity – a crucial factor in tumor formation. The research, which was funded in…...
2018 Gordon Research Conference on Nasopharyngeal Carcinoma
The Asian Fund for Cancer Research (AFCR) is pleased to be an official Contributor for the 2018 Gordon Research Conference (GRC) on nasopharyngeal carcinoma being held at the Hong Kong University of Science and Technology (HKUST) from June 24th to 29th. The event promises to gather 200 of not only…...
HPV vaccine is safe and reduces cell changes that can become cancer
Anne Li A vaccine designed to prevent cervical cancer is safe and effective in reducing cell changes that can become cancerous, a new review has confirmed. The human papilloma virus (HPV) vaccine reduces precancerous changes and doesn’t cause serious side effects, according to one of the largest reviews to date.…...
New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast Cancer
Research published today in Nature Medicine by scientists at the National Cancer Institute (NCI) has described a new immunotherapy approach, which led to a complete disappearance of tumors in a woman with advanced metastatic breast cancer who only had months to live. The findings show how naturally-occurring tumor infiltrating lymphocytes…...
Bracing for the ups and downs of biotech
There is a lot of excitement in our market over the new rules we introduced earlier this month to welcome new economy and pre-revenue biotech companies. We’ve already had several companies express interest in listing under the new rules, and we’ve heard a lot of positive things from investors who…...
Two Giants of Cancer Care® with AFCR Affiliation
Respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice were recognized on June 31st as Giants of Cancer Care in an event at the Adler Planetarium in Chicago. Two of the 21 honorees are Scientific Advisory Board members of the Asian…...
